Idera Pharmaceuticals Inc (NASDAQ:IDRA)

During the Trading Day
4.17 +0.28 / +7.20%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.17 +0.0005 / +0.01%
 
Volume: 26.0K
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$333.8M

Company Description

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in the discovery and development of novel synthetic DNA- and RNA-based drug candidates that are designed to modulate immune responses mediated through Toll-like Receptors. The company has two drug candidates, IMO-3100, a TLR7 and TLR9 antagonist, and IMO-8400, a TLR7, TLR8, and TLR9 antagonist, in clinical development for the treatment of autoimmune and inflammatory diseases. Idera Pharmaceuticals was founded by Paul C. Zamecnik, Sudhir A. Agrawal and James B. Wyngaarden in May 25, 1989 and is headquartered in Cambridge, MA.

Contact Information

Idera Pharmaceuticals, Inc.
167 Sidney Street
Cambridge Massachusetts 02139
P:(617) 679-5500
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Vincent J. MilanoPresident, Chief Executive Officer & Director
Louis J. ArcudiCFO, Secretary, Treasurer & SVP-Operations
Sudhir A. AgrawalDirector & President-Research
Robert D. ArbeitVice President-Clinical Development
Louis BrennerChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.